Qualcomm Tumbles 21% YTD; UPS Resets 03/11/26
/
RSS Feed
Qualcomm Tumbles 21% YTD; UPS Resets 03/11/26
Key Stories:
- Thermo Fisher Scientific, the life sciences giant, is grappling with fading stock momentum despite a steady stream of product launches and a new Cryo Electron Microscopy Drug Discovery Center in South San Francisco. The company also recently rolled out new chromogenic media to target drug-resistant Candida auris. However, investors have seen the stock’s 30-day share price return at 7.88% and its year-to-date return at 15.60%, which the latest analysis suggests indicates a slowdown. While innovation continues, the market seems to be scrutinizing the valuation against this recent performance. Investors will be watching if these new initiatives can re-ignite stronger share price growth. Read more
- UPS, the global parcel delivery service, is undertaking a significant operational reset after ending its long-standing relationship with Amazon. This move has fundamentally reshaped its U.S. domestic business, contributing to a 10.8% decline in U.S. domestic volume and putting substantial pressure on revenue. As part of this broad restructuring of its operating model and cost base, UPS is implementing widespread job cuts, affecting 48,000 positions. Management has characterized this strategic shift as a “historic inflection point” for the company, as it re-evaluates its exposure to U.S. e-commerce and business shipping in the wake of losing its largest customer. Read more
- Qualcomm, the semiconductor and wireless technology leader, has seen its shares plummet roughly 21% year-to-date. The stock closed Wednesday trading between $134 and $135 and shed another 3.65% just yesterday, March 10th. This sharp decline follows a wave of analyst downgrades, most notably a fresh Underperform call from Bank of America. The sell-side appears to be catching up to concerns about the company’s prospects, leading investors to question the current valuation and whether more downside is on the horizon. This significant correction prompts a closer look at Qualcomm’s fundamentals and future outlook. Read more
Keywords: Amazon, BAC, Bank of America, Cryo EM, NASDAQ:QCOM, NYSE:UPS, QCOM, Qualcomm, TMO, Thermo Fisher Scientific, UPS, Underperform, analyst downgrade, domestic volume, drug discovery, e-commerce, fungal diagnostics, job cuts, life sciences, momentum, operating model, parcel delivery, revenue pressure, semiconductor, share price, share price return, strategic shift, valuation, wireless technology, year-to-date